[Cardiovascular pharmacotherapy in the era of RNA-based precision medicine] [0.03%]
基于RNA的精准医学时代的心血管药物治疗
Anselm A Derda,Anna Hohneck
Anselm A Derda
In the pharmacotherapy of heart failure with reduced ejection fraction (HFrEF) in addition to the "fantastic four", a potential fifth pillar is emerging with low-dose digitoxin, while finerenone broadens the spectrum of mineralocorticoid re...
[Cardiovascular medicine 2026-overcoming boundaries together, setting standards] [0.03%]
[心血管医学2026——携手克服界限，共同树立标准]
Stephan Willems
Stephan Willems
Editorial
Herz. 2026 Mar;51(2):79-80. DOI:10.1007/s00059-026-05370-0 2026
Contemporary insights and evolving clinical pathways in transcatheter tricuspid valve replacement [0.03%]
经导管三尖瓣置换的最新见解和临床路径演变
J G da Rocha E Silva,L Stolz,H Kempton et al.
J G da Rocha E Silva et al.
Transcatheter tricuspid valve replacement (TTVR) has emerged as an important therapeutic option for patients with severe tricuspid regurgitation (TR), particularly those with high surgical risk and complex anatomy. This review summarizes th...
Review
Herz. 2026 Mar 3. DOI:10.1007/s00059-026-05371-z 2026
Dominik Berliner,Sven Schallhorn,Johann Bauersachs
Dominik Berliner
Severe tricuspid regurgitation (TR) is a common right-sided valvular disease associated with a substantially increased risk of morbidity, hospitalization, and mortality. Transcatheter tricuspid edge-to-edge repair (T-TEER) is a minimally in...
Erratum to: Atherogenic index as an associative marker for coronary artery disease [0.03%]
冠心病相关标志物动脉粥样硬化指数的影响因素及其与颈动脉内膜中层厚度的关系的更正
Basavaraj Utagi,Dilip Johny,Aditya Ojha et al.
Basavaraj Utagi et al.
Published Erratum
Herz. 2026 Feb 26. DOI:10.1007/s00059-026-05374-w 2026
Christos Iliadis,Stephan Baldus
Christos Iliadis
Mitral valve transcatheter edge-to-edge repair (M-TEER) has emerged as an alternative therapy for mitral regurgitation (MR), addressing the unmet clinical need for patients with high surgical risk. Previous large randomized controlled trial...
[Cardiac arrhythmias-Cellular mechanisms, consequences and challenges in the diagnostics using human models] [0.03%]
[心律失常-细胞机制，后果及人类模型诊断中的挑战]
Katrin Streckfuß-Bömeke,Christoph Maack,Samuel Sossalla
Katrin Streckfuß-Bömeke
Cardiac arrhythmias significantly contribute to morbidity and mortality in cardiovascular diseases. Hereditary ion channel disorders, including Brugada syndrome, long/short QT syndrome and catecholaminergic polymorphic ventricular tachycard...
[Sudden cardiac death in structural heart disease : Update on prevention] [0.03%]
[结构性心脏病患者的突发性心脏死亡：预防更新]
Nora Wainstejn,Alireza Sepehri Shamloo,Verena Tscholl et al.
Nora Wainstejn et al.
Sudden cardiac death (SCD) remains one of the leading causes of death despite major advances in cardiovascular diagnostics and treatment. Evidence supporting primary prophylactic implantable cardioverter defibrillator (ICD) implantation is ...
Anna Hohneck,Oliver Weingärtner
Anna Hohneck